NEW YORK (GenomeWeb News) — As expected, the Nasdaq Stock Market said it plans to file a petition with the US Securities and Exchange Commission to delist Tripos, the market said today.
 
Nasdaq said the delisting will become effective 10 days after the filing. Tripos has not traded on the Nasdaq since July 6, when the market suspended its stock.
  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.